ZOM

Zomedica Corp. ZOM

Trading inactive

ZOM
Zomedica Corp. OPTN
OptiNose, Inc. ASXC
Asensus Surgical, Inc. ZYNE
Zynerba Pharmaceuticals, Inc. UPXI
Upexi, Inc. AADI
Aadi Bioscience, Inc. JNCE
Jounce Therapeutics, Inc. IMDX
Insight Molecular Diagnostics Inc. MIRO
Miromatrix Medical Inc. HLVX
HilleVax, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ZOM OPTN ASXC ZYNE UPXI AADI JNCE IMDX MIRO HLVX
6M -25.15 % 52.38 % 20.80 % 266.20 % -82.67 % -4.65 % 109.45 % 50.63 % 78.42 % 23.67 %
YTD -29.59 % 43.28 % 9.27 % 136.79 % -50.40 % -34.71 % 72.48 % 104.29 % 0.00 % 0.48 %
1Y -31.58 % -43.36 % 21.01 % 99.39 % -57.79 % 12.64 % -49.19 % 116.36 % 5.33 % 11.76 %
3Y -71.36 % -82.02 % -80.88 % -64.67 % -97.42 % -86.82 % -65.94 % -15.90 % -77.76 % -87.39 %
5Y -40.53 % -90.15 % -96.12 % -78.15 % -98.33 % -76.30 % -74.83 % -90.33 % -77.76 % -89.05 %
10Y -88.26 % -96.63 % -99.33 % -92.00 % -98.33 % -97.72 % -89.10 % -97.05 % -77.76 % -89.05 %
From the beginning -88.26 % -96.63 % -99.95 % -92.00 % -98.33 % -97.72 % -89.10 % -97.05 % -77.76 % -89.05 %

Dividend